BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 10072435)

  • 1. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers.
    Simpkins SB; Bocker T; Swisher EM; Mutch DG; Gersell DJ; Kovatich AJ; Palazzo JP; Fishel R; Goodfellow PJ
    Hum Mol Genet; 1999 Apr; 8(4):661-6. PubMed ID: 10072435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers.
    Whelan AJ; Babb S; Mutch DG; Rader J; Herzog TJ; Todd C; Ivanovich JL; Goodfellow PJ
    Int J Cancer; 2002 Jun; 99(5):697-704. PubMed ID: 12115503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas.
    Esteller M; Levine R; Baylin SB; Ellenson LH; Herman JG
    Oncogene; 1998 Nov; 17(18):2413-7. PubMed ID: 9811473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsatellite instability, MLH1 promoter methylation, and loss of mismatch repair in endometrial cancer and concomitant atypical hyperplasia.
    Horowitz N; Pinto K; Mutch DG; Herzog TJ; Rader JS; Gibb R; Bocker-Edmonston T; Goodfellow PJ
    Gynecol Oncol; 2002 Jul; 86(1):62-8. PubMed ID: 12079302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite instability and expression of MLH1 and MSH2 in normal and malignant endometrial and ovarian epithelium in hereditary nonpolyposis colorectal cancer family members.
    Ichikawa Y; Lemon SJ; Wang S; Franklin B; Watson P; Knezetic JA; Bewtra C; Lynch HT
    Cancer Genet Cytogenet; 1999 Jul; 112(1):2-8. PubMed ID: 10432927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers.
    Kuismanen SA; Holmberg MT; Salovaara R; de la Chapelle A; Peltomäki P
    Am J Pathol; 2000 May; 156(5):1773-9. PubMed ID: 10793088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of hMLH1 in a population-based series of endometrial carcinomas.
    Salvesen HB; MacDonald N; Ryan A; Iversen OE; Jacobs IJ; Akslen LA; Das S
    Clin Cancer Res; 2000 Sep; 6(9):3607-13. PubMed ID: 10999752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study.
    Stefansson I; Akslen LA; MacDonald N; Ryan A; Das S; Jacobs IJ; Salvesen HB
    Clin Cancer Res; 2002 Jan; 8(1):138-43. PubMed ID: 11801550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine.
    Planck M; Ericson K; Piotrowska Z; Halvarsson B; Rambech E; Nilbert M
    Cancer; 2003 Mar; 97(6):1551-7. PubMed ID: 12627520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite instability and expression of mismatch repair genes in sporadic endometrial cancer coexisting with colorectal or breast cancer.
    Takano K; Ichikawa Y; Ueno E; Ohwada M; Suzuki M; Tsunoda H; Miwa M; Uchida K; Yoshikawa H
    Oncol Rep; 2005 Jan; 13(1):11-6. PubMed ID: 15583795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer.
    Berends MJ; Hollema H; Wu Y; van Der Sluis T; Mensink RG; ten Hoor KA; Sijmons RH; de Vries EG; Pras E; Mourits MJ; Hofstra RM; Buys CH; Kleibeuker JH; van Der Zee AG
    Int J Cancer; 2001 May; 92(3):398-403. PubMed ID: 11291077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer.
    Raedle J; Trojan J; Brieger A; Weber N; Schäfer D; Plotz G; Staib-Sebler E; Kriener S; Lorenz M; Zeuzem S
    Ann Intern Med; 2001 Oct; 135(8 Pt 1):566-76. PubMed ID: 11601928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers.
    Kanaya T; Kyo S; Maida Y; Yatabe N; Tanaka M; Nakamura M; Inoue M
    Oncogene; 2003 Apr; 22(15):2352-60. PubMed ID: 12700670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis.
    Peterson LM; Kipp BR; Halling KC; Kerr SE; Smith DI; Distad TJ; Clayton AC; Medeiros F
    Int J Gynecol Pathol; 2012 May; 31(3):195-205. PubMed ID: 22498935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
    Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
    Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite instability and hMLH1/hMSH2 expression in young endometrial carcinoma patients: associations with family history and histopathology.
    Parc YR; Halling KC; Burgart LJ; McDonnell SK; Schaid DJ; Thibodeau SN; Halling AC
    Int J Cancer; 2000 Apr; 86(1):60-6. PubMed ID: 10728595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective mismatch repair and the development of recurrent endometrial carcinoma.
    Pijnenborg JM; Dam-de Veen GC; de Haan J; van Engeland M; Groothuis PG
    Gynecol Oncol; 2004 Aug; 94(2):550-9. PubMed ID: 15297202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.